The Company

Cryopreservation is a critical platform technology for biomedical research and clinical applications. There are numerous cell and tissue types that (a) cannot be cryopreserved or (b) can be cryopreserved, but lose viability during the freeze-thaw process. CryoCrate is focused on revolutionizing cryopreservation in the life sciences, specifically concentrating on cells and tissues that currently cannot be maintained under current medium and long-term storage solutions.

CryoCrate intends to be the premier supplier of cryopreservation solutions to the life science and clinical markets and is exploring global opportunities available in both markets.

Recent Events and Awards

2019: CryoCrate received a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase II award ($1.5M) for corneal and bioartificial tissue cryopreservation technology development.

2018: CryoCrate received a NIH SBIR award for stem cell cryopreservation.

2018: CryoCrate received a National Institute of Food and Agriculture SBIR award for cryopreservation of livestock embryos and semen in agricultural applications.

2018: Dr. Han received a Coulter Partnership award for cryopreservation of blood vessels, myocardium tissues and the whole rodent hearts.

2017: CryoCrate C80EZ® products entered into the market.

2017: CryoCrate received the first round of outside investment.

2016: Dr. Han received a Fast-Track Award from the University of Missouri for cryopreservation media GMP production and a Coulter Partnership award for an innovative device for the cryopreservation of corneas.

2015: CryoCrate received a NIH SBIR award for novel cryopreservation device development.